Diabetes Dialogue: Making Sense of Semaglutide in Type 1 Dia

In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and their real-world experiences with GLP-1 use in people with type 1 diabetes.

Related Keywords

Eli Lilly , Natalie Bellini , Diana Isaacs , Provention Bio , Diabetes Technology At University Hospitals , Training In Diabetes Technology , Medtronic , Metabolic Care Center , Novo Nordisk , University Of New York At Buffalo , New England Journal , State University , New York , Diabetes Technology , University Hospitals Diabetes , Metabolic Care , Diabetes Dialogue , Real World Perspectives , Endocrine Disorders , Abbott Diabetes Care ,